Yu-Tao Xiang, MD, PhD

Early treatment response in adults with acute mania is a good predictor of ultimate response and remission. Read this article by Xiao and colleagues to see if response to...

Only 30% to 60% of patients with treatment-resistant schizophrenia benefit from clozapine monotherapy. Does augmentation with mood stabilizers/antiepileptics improve the chances of success? This meta-analysis of 22 randomized controlled...